Cherry Simon R
Center for Molecular and Genomic Imaging, Department of Biomedical Engineering, University of California-Davis, Davis, California, USA.
J Nucl Med. 2006 Nov;47(11):1735-45.
There have been major advances in PET technology that cumulatively have helped improve image quality, increased the range of applications for PET, and contributed to the more widespread use of PET. Examples of these technologic advances include whole-body imaging, 3-dimensional imaging, new scintillator materials, iterative reconstruction algorithms, combined PET/CT, and preclinical PET. New advances on the immediate horizon include the reintroduction of time-of-flight PET, which takes advantage of the favorable timing properties of newer scintillators; the integration of PET and MRI scanners into a dual-modality imaging system; and the possibility of further significant improvements in spatial resolution in preclinical PET systems. Sensitivity remains a limiting factor in many PET studies. Although, conceptually, huge gains in sensitivity are still possible, realizing these gains is thwarted largely by economic rather than scientific concerns. Predicting the future is fraught with difficulty; nonetheless, it is apparent that ample opportunities remain for new development and innovation in PET technology that will be driven by the demands of molecular medicine, notably sensitive and specific molecular diagnostic tools and the ability to quantitatively monitor therapeutic entities that include small molecules, peptides, antibodies, nanoparticles, DNA/RNA, and cells.
正电子发射断层扫描(PET)技术取得了重大进展,这些进展累积起来有助于提高图像质量、扩大PET的应用范围,并促使PET得到更广泛的使用。这些技术进步的例子包括全身成像、三维成像、新型闪烁体材料、迭代重建算法、PET/CT联合成像以及临床前PET。即将出现的新进展包括重新引入飞行时间PET,它利用了新型闪烁体有利的时间特性;将PET和磁共振成像(MRI)扫描仪整合到双模态成像系统中;以及临床前PET系统在空间分辨率方面进一步大幅提高的可能性。在许多PET研究中,灵敏度仍然是一个限制因素。虽然从概念上讲,灵敏度仍有可能大幅提高,但实现这些提高在很大程度上受到经济而非科学问题的阻碍。预测未来充满困难;尽管如此,显然PET技术仍有大量新的发展和创新机会,这些机会将由分子医学的需求驱动,特别是灵敏且特异的分子诊断工具以及定量监测包括小分子、肽、抗体、纳米颗粒、DNA/RNA和细胞在内的治疗实体的能力。